Zhi Dong Pan

Director/Board Member at MabPlex International Co., Ltd.

40 year

Non-Energy Minerals

Health Technology

Consumer Services

Profile

Zhi Dong Pan is currently a Director at MabPlex International Co., Ltd.
He previously served as a Member-Supervisory Board at Dalian Huarui Heavy Industry Group Co., Ltd.
He earned a doctorate degree from Dalian Maritime University in 2017.

Zhi Dong Pan active positions

Companies	Position	Start
MabPlex International Co., Ltd. MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China.	Director/Board Member	2020-02-29

All active positions of Zhi Dong Pan

Former positions of Zhi Dong Pan

Companies	Position	End
DALIAN HUARUI HEAVY INDUSTRY GROUP CO., LTD.	Director/Board Member	-

See the detail of Zhi Dong Pan's experience

Training of Zhi Dong Pan

Dalian Maritime University

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Zhi Dong Pan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
DALIAN HUARUI HEAVY INDUSTRY GROUP CO., LTD.	Non-Energy Minerals

Private companies	1
MabPlex International Co., Ltd. MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China.	Health Technology